← Back to headlines
Eli Lilly Expands Pipeline with Positive Trial Data and New Licensing Deal
Eli Lilly (LLY) has announced the expansion of its pharmaceutical pipeline, driven by positive trial data and a new licensing agreement.
23 Feb, 19:51 — 23 Feb, 19:51
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Understanding Emotional Intelligence and Its Importance for Success
6m ago
Christina Applegate Opens Up About Her Battle with Multiple Sclerosis
10m ago
Relatives Allege Misdiagnosis in Death of 46-Year-Old Sailor in Skyros
13m ago
Man Arrested After Patient Dies from Drug Poisoning in Pula Hospital
15m ago